|
|
 |
|
Eight of the World’s Top 20 Pharmaceutical Companies now license Argus Safety™.
Irvine, Calif. – July 15, 2008 – Relsys International, the leading provider of drug safety, pharmacovigilance and risk management solutions for the pharmaceutical industry, announces that one of the world’s largest biotechnology companies has migrated to Argus Safety™ from another commercial system. The company has been listed on Pharmaceutical Executive’s list of largest pharmaceutical companies for numerous years.
John Loucks, Relsys’ Chief Customer Officer, commented: “This is the third global Top 15 company to have migrated to Argus Safety™ in the past four months, validating that Relsys is the premier drug safety and risk management provider. Argus Safety™ is the world’s most widely used pharmacovigilance system precisely because it addresses the industry’s demanding technology and performance needs, while always remaining proactive on complex global regulatory requirements.”
Relsys Chief Services Officer Chris Jabbal added: “Relsys’ Global Professional Services (GPS) group is enthusiastic about adding this project to its portfolio. Our team of experienced consultants will work closely with the company throughout the project to deliver a successful deployment. In the past two years, we have progressively scaled our GPS capacity to take on new projects and we have successfully completed dozens of projects world wide. We are confident that we will satisfy our latest client as well.”
Parties interested in learning more about the Argus Safety™ Suite, including the most advanced risk management capabilities in the industry, can contact us at info@relsys.net.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for Drug Safety, Pharmacovigilance and Risk Management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety™, the company’s flagship product, is the world’s widely-used drug safety and adverse event reporting software. Relsys is a privately held company, headquartered in Irvine, California. For more information, visit www.relsys.net, or call +1 949-453-1715.
Back to News Headlines
|
|
